- Home
- MRUS vs GBCI Comparison
MRUS vs GBCI Comparison
Compare MRUS & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- GBCI
- Stock Information
- Founded
- MRUS 2003
- GBCI 1955
- Country
- MRUS Netherlands
- GBCI United States
- Employees
- MRUS N/A
- GBCI N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- GBCI Major Banks
- Sector
- MRUS Health Care
- GBCI Finance
- Exchange
- MRUS Nasdaq
- GBCI Nasdaq
- Market Cap
- MRUS 5.1B
- GBCI 5.1B
- IPO Year
- MRUS 2016
- GBCI N/A
- Fundamental
- Price
- MRUS $68.95
- GBCI $50.14
- Analyst Decision
- MRUS Strong Buy
- GBCI Buy
- Analyst Count
- MRUS 13
- GBCI 6
- Target Price
- MRUS $92.15
- GBCI $50.50
- AVG Volume (30 Days)
- MRUS 629.8K
- GBCI 623.8K
- Earning Date
- MRUS 10-30-2025
- GBCI 10-23-2025
- Dividend Yield
- MRUS N/A
- GBCI 2.65%
- EPS Growth
- MRUS N/A
- GBCI 17.64
- EPS
- MRUS N/A
- GBCI 1.93
- Revenue
- MRUS $56,228,000.00
- GBCI $855,046,000.00
- Revenue This Year
- MRUS $48.69
- GBCI $16.01
- Revenue Next Year
- MRUS $3.15
- GBCI $25.89
- P/E Ratio
- MRUS N/A
- GBCI $25.90
- Revenue Growth
- MRUS 59.77
- GBCI 11.62
- 52 Week Low
- MRUS $33.19
- GBCI $36.76
- 52 Week High
- MRUS $70.65
- GBCI $60.67
- Technical
- Relative Strength Index (RSI)
- MRUS 57.97
- GBCI 63.73
- Support Level
- MRUS $66.49
- GBCI $47.04
- Resistance Level
- MRUS $69.63
- GBCI $49.38
- Average True Range (ATR)
- MRUS 2.46
- GBCI 1.12
- MACD
- MRUS -0.07
- GBCI -0.12
- Stochastic Oscillator
- MRUS 78.37
- GBCI 89.60
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About GBCI Glacier Bancorp Inc.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.